Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/151863

Título:	Benefits and harm of systemic steroids for short- And long-term use in rhinitis and rhinosinusitis: an EAACI position paper
Autor/a:	Hox, Valerie; Lourijsen, Evelijn; Jordens, Arnout; Aasbjerg, Kristian; Agache, Ioana; Alobid, Isam; Bachert, Claus; Boussery, Koen; Campo, Paloma; Fokkens, Wytske; Hellings, Peter; Hopkins, Claire; Klimek, Ludger; Mäkelä, Mika; Mösges, Ralph; Mullol i Miret, Joaquim; Pujols Tarrés, Laura; Rondon, Carmen; Rudenko, Michael; Toppila‑Salmi, Sanna; Scadding, Glenis; Scheire, Sophie; Tomazic, Peter‑Valentin; Van Zele, Thibaut; Wagemann, Martin; van Boven, Job F. M.; Gevaert, Philippe
Notas:	Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that - potentially severe - side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.
Materia(s):	-Rinitis -Glucocorticoides -Rhinitis -Glucocorticoids
Derechos:	cc by (c) Hox et al., 2020 http://creativecommons.org/licenses/by/3.0/es/
Tipo de documento:	Artículo Artículo - Versión publicada
Editor:	BioMed Central
Compartir:

Mostrar el registro completo del ítem